Hyogo, Japan

Yasuhiro Tosaka

This inventor holds 2 USPTO granted patents. Top assignees: Jcr Pharmaceuticals Co., Ltd., Kanazawa University, Saint Louis University. Active years: 2011-2012.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasuhiro Tosaka: Innovator in Fusion Protein Technology

Introduction

Yasuhiro Tosaka is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Tosaka's latest patents include a groundbreaking fusion protein that comprises the enzyme N-acetylgalactosamine-6-sulfate sulfatase. This protein is attached to a short peptide consisting of 4-15 acidic amino acids on its N-terminal side. The invention also includes a pharmaceutical composition containing this fusion protein and a method for treating type A Morquio disease. Compared to the native enzyme protein, this fusion protein exhibits higher transferability to bone tissues and improved stability in the blood.

Career Highlights

Throughout his career, Yasuhiro Tosaka has worked with esteemed institutions such as Saint Louis University and Kanazawa University. His research has focused on enhancing the efficacy of therapeutic proteins, which has the potential to significantly impact patient care.

Collaborations

Tosaka has collaborated with notable colleagues, including Shunji Tomatsu and Ken'ichi Miyamoto. Their combined expertise has contributed to the advancement of research in the field of fusion proteins.

Conclusion

Yasuhiro Tosaka's innovative work in fusion protein technology showcases his commitment to improving medical treatments. His patents reflect a significant advancement in the field, particularly for conditions like type A Morquio disease.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…